KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) EBT (2016 - 2025)

Historic EBT for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to -$50.2 million.

  • Teladoc Health's EBT fell 5454.83% to -$50.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.1 million, marking a year-over-year increase of 7424.1%. This contributed to the annual value of -$993.7 million for FY2024, which is 35246.67% down from last year.
  • Per Teladoc Health's latest filing, its EBT stood at -$50.2 million for Q3 2025, which was down 5454.83% from -$40.4 million recorded in Q2 2025.
  • Teladoc Health's 5-year EBT high stood at -$25.4 million for Q4 2023, and its period low was -$6.7 billion during Q1 2022.
  • Moreover, its 5-year median value for EBT was -$74.6 million (2022), whereas its average is -$813.9 million.
  • Per our database at Business Quant, Teladoc Health's EBT tumbled by 617723.22% in 2022 and then soared by 9933.43% in 2023.
  • Quarter analysis of 5 years shows Teladoc Health's EBT stood at -$60.7 million in 2021, then crashed by 6177.23% to -$3.8 billion in 2022, then skyrocketed by 99.33% to -$25.4 million in 2023, then crashed by 89.84% to -$48.2 million in 2024, then decreased by 4.26% to -$50.2 million in 2025.
  • Its EBT stands at -$50.2 million for Q3 2025, versus -$40.4 million for Q2 2025 and -$111.3 million for Q1 2025.